New Tool Supercharges Immunotherapy Against Prostate Cancer
Reported bySciTechDaily ↗·Sourced by Goodlede
Researchers at University of Rochester developed a CRISPR-based treatment that changes how prostate cancer cells process messenger RNA, drawing more immune cells into tumors and making immune checkpoint therapy significantly more effective in mice.
The findings are limited to mouse models.
Goodlede runs a two-pass source check on every story: one pass finds it, a second skeptical pass re-verifies the claim and writes what it doesn’t prove. This is a source check, not an independent fact-check — confirm anything important at the link above.
Read the full story at SciTechDaily
Read original story ↗More good news, verified daily.
Goodlede covers positive developments across science, nature, rights, and human achievement — verified before they appear. No hype, no roundups, no PR wires.
© 2026 Wag Media, LLC
More from Goodlede
Environment
Brazil's Amazon sees sharp decline in size of area burned in 2025
BBC Science & Environment · Verified
Environment
How farmers could fix Wales' polluted rivers and save money
BBC News · Verified
Science
Could Life Exist on This Nearby World? In a First, Astronomers Find an Atmosphere on an Earth-Like Exoplanet in the Habitable Zone
Smithsonian Smart News · Verified